Literature DB >> 27799161

Gene-corrected human Munc13-4-deficient CD8+ T cells can efficiently restrict EBV-driven lymphoproliferation in immunodeficient mice.

Tayebeh Soheili1,2,3, Julie Rivière1,2, Ida Ricciardelli4, Amandine Durand1,2, Els Verhoeyen5,6, Anne-Céline Derrien1,2, Chantal Lagresle-Peyrou1,2,3, Geneviève de Saint Basile2,7,8, François-Loïc Cosset5, Persis Amrolia4, Isabelle André-Schmutz1,2, Marina Cavazzana1,2,3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27799161     DOI: 10.1182/blood-2016-07-729871

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Lentiviral Gene Therapy for Familial Hemophagocytic Lymphohistiocytosis Type 3, Caused by UNC13D Genetic Defects.

Authors:  Sarah E Takushi; Na Yoon Paik; Andrew Fedanov; Chengyu Prince; Christopher B Doering; H Trent Spencer; Shanmuganathan Chandrakasan
Journal:  Hum Gene Ther       Date:  2020-06       Impact factor: 5.695

2.  Gene transfer into hematopoietic stem cells reduces HLH manifestations in a murine model of Munc13-4 deficiency.

Authors:  Tayebeh Soheili; Amandine Durand; Fernando E Sepulveda; Julie Rivière; Chantal Lagresle-Peyrou; Hanem Sadek; Geneviève de Saint Basile; Samia Martin; Fulvio Mavilio; Marina Cavazzana; Isabelle André-Schmutz
Journal:  Blood Adv       Date:  2017-12-21

3.  Alternative UNC13D Promoter Encodes a Functional Munc13-4 Isoform Predominantly Expressed in Lymphocytes and Platelets.

Authors:  Donatella Galgano; Tayebeh Soheili; Matthias Voss; Lamberto Torralba-Raga; Bianca Tesi; Frank Cichocki; Isabelle Andre; Jens Rettig; Marina Cavazzana; Yenan Bryceson
Journal:  Front Immunol       Date:  2020-06-09       Impact factor: 7.561

4.  A Nontoxic Transduction Enhancer Enables Highly Efficient Lentiviral Transduction of Primary Murine T Cells and Hematopoietic Stem Cells.

Authors:  Marianne Delville; Tayebeh Soheili; Florence Bellier; Amandine Durand; Adeline Denis; Chantal Lagresle-Peyrou; Marina Cavazzana; Isabelle Andre-Schmutz; Emmanuelle Six
Journal:  Mol Ther Methods Clin Dev       Date:  2018-08-08       Impact factor: 6.698

Review 5.  Haematopoietic Stem Cell Transplantation for Primary Haemophagocytic Lymphohistiocytosis.

Authors:  Kai Lehmberg; Despina Moshous; Claire Booth
Journal:  Front Pediatr       Date:  2019-10-25       Impact factor: 3.418

Review 6.  Gene Therapy for Primary Immunodeficiency.

Authors:  Benjamin C Houghton; Claire Booth
Journal:  Hemasphere       Date:  2020-12-29

Review 7.  Gene Edited T Cell Therapies for Inborn Errors of Immunity.

Authors:  T A Fox; B C Houghton; C Booth
Journal:  Front Genome Ed       Date:  2022-06-16

8.  Gene therapy for severe combined immunodeficiencies and beyond.

Authors:  Alain Fischer; Salima Hacein-Bey-Abina
Journal:  J Exp Med       Date:  2020-01-06       Impact factor: 14.307

Review 9.  Recent advances in primary immunodeficiency: from molecular diagnosis to treatment.

Authors:  Giorgia Bucciol; Isabelle Meyts
Journal:  F1000Res       Date:  2020-03-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.